American Healthcare REIT Inc AHR.N, AHR is expected to show a rise in quarterly revenue when it reports results on February 27 for the period ending December 31 2024
The Irvine California-based company is expected to report a 11.8% increase in revenue to $539.529 million from $482.58 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for American Healthcare REIT Inc is for earnings of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for American Healthcare REIT Inc is $30.00, above its last closing price of $27.75.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.30 | 0.31 | 0.36 | Beat | 17.9 |
Jun. 30 2024 | 0.29 | 0.29 | 0.33 | Beat | 13.8 |
Mar. 31 2024 | 0.30 | 0.30 | 0.30 | Met | 1.1 |
Dec. 31 2023 | 0.30 | 0.31 | 0.38 | Beat | 21 |
| |||||
|
This summary was machine generated February 25 at 21:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。